PPP2R2A and non-small cell lung carcinoma: Nevertheless, also BRCA-independent defects in HR-mediated DNA repair e.g. by downregulation of protein phosphatase 2 regulatory subunit B alpha (PPP2R2A) in non-small cell lung cancer cells promoted increased sensitivity to PARP inhibitors in vitro and in vivo [50].